Targeting fibroblast derived thrombospondin 2 disrupts an immune-exclusionary environment at the tumor front in colorectal cancer
Open Access
- 23 November 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1)
Abstract
Fibrotic colorectal cancers (CRC) are largely microsatellite-stable and display desmoplastic stroma with poor immune infiltration. Here we identify thrombospondin-2 (THBS2) as a key regulator of the immune-exclusionary phenotype in fibrotic CRC. THBS2 is highly expressed by matrix cancer-associated fibroblasts at the tumor front. In an orthotopic model using desmoplastic tumor organoids, global or fibroblast-specific Thbs2 deletion disrupts the exclusionary barrier and increases intratumoral CD8 T cells. Mechanistically, THBS2 limits recruitment of CXCR3+ CD8 T cells by restraining dendritic- and macrophage-derived CXCL9/10. Depletion of these myeloid cells or blockade of CXCL9/10-CXCR3 signaling abolishes the enhanced CD8 T-cell influx and antitumor efficacy. Spatial profiling demonstrates that THBS2 loss induces proximity between CD8 T cells and myeloid cells and upregulates chemokines. Despite increased infiltration, CD8 T cells manifest exhaustion, rendering tumors highly susceptible to immune checkpoint blockade. THBS2 thus represents a tractable CAF-restricted target to overcome immune exclusion in fibrotic CRCs.Keywords
Funding Information
- MEXT | Japan Society for the Promotion of Science (23H02891)
- MEXT | Japan Society for the Promotion of Science (25K02638)
- MEXT | Japan Society for the Promotion of Science (23K27582)
- Japan Agency for Medical Research and Development (25ama221326h0001)
- Japan Agency for Medical Research and Development (25ama221444h0001)
- Cabinet Office, Government of Japan (JP22zf0127009)
This publication has 62 references indexed in Scilit:
- THBS2-producing matrix CAFs promote colorectal cancer progression and link to poor prognosis via the CD47-MAPK axisCell Reports, 2025
- Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancerCancer Cell, 2022
- Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin αvβ3/CD36-mediated activation of the MAPK pathwayCancer Letters, 2022
- Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancerCancer Cell, 2022
- The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal CancerCurrent Treatment Options in Oncology, 2021
- CytoMAP: A Spatial Analysis Toolbox Reveals Features of Myeloid Cell Organization in Lymphoid TissuesCell Reports, 2020
- Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon CancerCell, 2020
- Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human MelanomaCell, 2018
- Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell TherapyCancer Cell, 2017
- Cre recombinase‐mediated gene targeting of mesenchymal cellsGenesis, 2004